Overview


According to FutureWise analysis, the MRI Safe Cardiac Resynchronization Therapy Device market in 2026 is US$0.84 billion, and is expected to reach US$1.75 billion by 2036 at a CAGR of 7.62%. 

The MRI Safe Cardiac Resynchronization Therapy (CRT) Device market is experiencing significant growth, primarily driven by the increasing prevalence of heart failure and the rising need for patients with implanted cardiac devices to undergo MRI examinations for various medical conditions. The introduction of MRI-conditional CRT devices has filled a crucial clinical gap, allowing patients to safely access this vital diagnostic imaging without the need for device explantation. Technological advancements in lead design, pulse generator shielding, and filtering systems are improving the safety and performance of these devices within MRI environments. Additionally, the aging global population and the growing incidence of cardiovascular diseases are expanding the patient pool that requires both CRT therapy and MRI compatibility. Regulatory approvals and clinical guidelines supporting the use of MRI-safe cardiac devices are further accelerating market adoption across healthcare facilities worldwide.

FutureWise Market Research has instantiated a report that provides an intricate analysis of MRI Safe Cardiac Resynchronization Therapy Device Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the MRI Safe Cardiac Resynchronization Therapy Device Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Medtronic
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • LivaNova PLC
  • MicroPort Scientific Corporation
  • Sorin Group
  • St. Jude Medical, Inc.
  • Philips Healthcare
  • Siemens Healthineers
  • GE Healthcare
  • ZOLL Medical Corporation
  • Schiller AG
  • Esaote SpA
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Koninklijke Philips N.V.
  • Shimadzu Corporation
  • Hitachi Medical Systems
  • Mindray Medical International Limited

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • MrI Safe Cardiac Resynchronization Therapy - Defibrillator
  • MrI Safe Cardiac Resynchronization Therapy - Pacemaker

By Age Group

  • Paediatric MrI Safe Cardiac Resynchronization Therapy Device
  • Geriatric MrI Safe Cardiac Resynchronization Therapy Device

By Indication

  • Cardiomyopathy
  • Bradycardia
  • Electrocardiography
  • Congestive Heart Failure

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the MRI Safe Cardiac Resynchronization Therapy Device Market By Product Type, By Age Group, By Indication and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   MRI Safe Cardiac Resynchronization Therapy Device Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of MRI Safe Cardiac Resynchronization Therapy Device Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   MRI Safe Cardiac Resynchronization Therapy Device Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   MRI Safe Cardiac Resynchronization Therapy Device Market, By Product Type Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. MrI Safe Cardiac Resynchronization Therapy - Defibrillator
        2. MrI Safe Cardiac Resynchronization Therapy - Pacemaker

  • 8.   MRI Safe Cardiac Resynchronization Therapy Device Market, By Age Group Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Paediatric MrI Safe Cardiac Resynchronization Therapy Device
        2. Geriatric MrI Safe Cardiac Resynchronization Therapy Device

  • 9.   MRI Safe Cardiac Resynchronization Therapy Device Market, By Indication Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Cardiomyopathy
        2. Bradycardia
        3. Electrocardiography
        4. Congestive Heart Failure

  • 10.   North America MRI Safe Cardiac Resynchronization Therapy Device Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 11.   Latin America MRI Safe Cardiac Resynchronization Therapy Device Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 12.   Europe MRI Safe Cardiac Resynchronization Therapy Device Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 13.   Asia Pacific MRI Safe Cardiac Resynchronization Therapy Device Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 14.   Middle East and Africa MRI Safe Cardiac Resynchronization Therapy Device Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Boston Scientific Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Abbott Laboratories
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Biotronik SE & Co. KG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. LivaNova PLC
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. MicroPort Scientific Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Sorin Group
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. St. Jude Medical, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Philips Healthcare
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
       10. Siemens Healthineers
        10.1. Company Overview
        10.2. Product Portfolio
        10.3. SWOT Analysis
        10.4. Financial Overview
        10.5. Strategic Overview
       11. GE Healthcare
        11.1. Company Overview
        11.2. Product Portfolio
        11.3. SWOT Analysis
        11.4. Financial Overview
        11.5. Strategic Overview
       12. ZOLL Medical Corporation
        12.1. Company Overview
        12.2. Product Portfolio
        12.3. SWOT Analysis
        12.4. Financial Overview
        12.5. Strategic Overview
       13. Schiller AG
        13.1. Company Overview
        13.2. Product Portfolio
        13.3. SWOT Analysis
        13.4. Financial Overview
        13.5. Strategic Overview
       14. Esaote SpA
        14.1. Company Overview
        14.2. Product Portfolio
        14.3. SWOT Analysis
        14.4. Financial Overview
        14.5. Strategic Overview
       15. Canon Medical Systems Corporation
        15.1. Company Overview
        15.2. Product Portfolio
        15.3. SWOT Analysis
        15.4. Financial Overview
        15.5. Strategic Overview
       16. Fujifilm Holdings Corporation
        16.1. Company Overview
        16.2. Product Portfolio
        16.3. SWOT Analysis
        16.4. Financial Overview
        16.5. Strategic Overview
       17. Koninklijke Philips N.V.
        17.1. Company Overview
        17.2. Product Portfolio
        17.3. SWOT Analysis
        17.4. Financial Overview
        17.5. Strategic Overview
       18. Shimadzu Corporation
        18.1. Company Overview
        18.2. Product Portfolio
        18.3. SWOT Analysis
        18.4. Financial Overview
        18.5. Strategic Overview
       19. Hitachi Medical Systems
        19.1. Company Overview
        19.2. Product Portfolio
        19.3. SWOT Analysis
        19.4. Financial Overview
        19.5. Strategic Overview
       20. Mindray Medical International Limited
        20.1. Company Overview
        20.2. Product Portfolio
        20.3. SWOT Analysis
        20.4. Financial Overview
        20.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients